any news is good news at the moment. i like how the financial review has titled that section of the paper as INSIDE PLAYS... i think INSIDER TRADER might have been a bit naughty...lmao.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%